Anil Sheth
Houston, TXNPI 1790755288
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,592 of the $3,530 with a category attached, or 73.4%. 20 manufacturers reported payments, led by Janssen Research & Development, LLC at 24.6% of the total.
Across 83 payments — averaging $42.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Janssen Research & Development, LLC$869
- Amgen$337
- Johnson & Johnson$261
- Otsuka America Pharmaceutical, Inc.$234
- Mallinckrodt Hospital Products Inc.$233
- Mallinckrodt Enterprises LLC$227
- plus $1K from 14 others
Across 1 payment — averaging $12,605 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AstraZeneca$13K
What the payments were for
- Travel & lodging$86925%
- Food & beverage$2,59273%
- Education$692%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Janssen Research & Development, LLC | 2 | $869 |
| Amgen(2 entities) | 20 | $337 |
| Johnson & Johnson | 3 | $261 |
| Otsuka America Pharmaceutical, Inc. | 13 | $234 |
| Mallinckrodt Hospital Products Inc. | 9 | $233 |
| Mallinckrodt Enterprises LLC | 9 | $227 |
| E.r. Squibb & Sons, L.L.C. | 2 | $222 |
| Actelion Pharmaceuticals US, Inc. | 2 | $218 |
| AbbVie | 2 | $205 |
| Paratek Pharmaceuticals, Inc. | 2 | $202 |
| Vifor Pharma, Inc. | 8 | $142 |
| Abbott | 1 | $127 |
| Insmed, Inc. | 1 | $106 |
| Fresenius USA Marketing, Inc. | 3 | $57 |
| Shire North American Group Inc | 1 | $19 |
| Sanofi | 1 | $19 |
| Pfizer | 1 | $14 |
| AstraZeneca | 1 | $14 |
| Travere Therapeutics, Inc. | 1 | $13 |
| Akebia Therapeutics Inc | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.